NYSE: BHVN
Biohaven Ltd Stock Ownership - Who owns Biohaven?

Insider buying vs selling

Have Biohaven Ltd insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
George C. ClarkVP Chief Accounting Officer2025-01-051,117$38.64
$43.16kSell
Kimberly GentileSVP Clinical Operations2025-01-051,956$38.64
$75.58kSell
Matthew ButenChief Financial Officer2025-01-052,561$38.64
$98.96kSell
Bruce CarChief Scientific Officer2025-01-052,331$38.64
$90.07kSell
Vlad CoricChief Executive Officer2025-01-056,805$38.64
$262.95kSell
John W. ChildsDirector2024-12-3029,000$35.95
$1.04MBuy
John W. ChildsDirector2024-10-0221,052$47.50
$999.97kBuy
Vlad CoricChief Executive Officer2024-10-0221,052$47.50
$999.97kBuy
Gregory BaileyDirector2024-09-245,000$44.19
$220.97kBuy
John W. ChildsDirector2024-07-1828,400$35.67
$1.01MBuy

1 of 2

BHVN insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when BHVN insiders and whales buy or sell their stock.

BHVN Shareholders

What type of owners hold Biohaven Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
John W. Childs12.07%12,201,947$505.53MInsider
Vanguard Group Inc8.32%8,414,120$348.60MInstitution
Blackrock Inc7.58%7,667,188$317.65MInstitution
Janus Henderson Group PLC6.90%6,982,425$289.28MInstitution
Suvretta Capital Management LLC5.56%5,620,271$232.85MInstitution
Vlad Coric4.86%4,916,101$203.67MInsider
Farallon Capital Management LLC4.38%4,428,167$183.46MInstitution
State Street Corp3.47%3,512,478$145.52MInstitution
Price T Rowe Associates Inc3.37%3,412,191$141.37MInstitution
Rp Management LLC2.90%2,936,507$121.66MInstitution

1 of 3

BHVN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BHVN70.66%19.00%Net BuyingNet Buying
CRSP64.53%35.47%Net BuyingNet Selling
SWTX60.02%39.98%Net SellingNet Selling
PTCT74.25%18.50%Net SellingNet Selling
KRYS76.61%23.39%Net SellingNet Selling

Biohaven Stock Ownership FAQ

Who owns Biohaven?

Biohaven (NYSE: BHVN) is owned by 70.66% institutional shareholders, 19.00% Biohaven insiders, and 10.35% retail investors. John W. Childs is the largest individual Biohaven shareholder, owning 12.20M shares representing 12.07% of the company. John W. Childs's Biohaven shares are currently valued at $505.53M.

If you're new to stock investing, here's how to buy Biohaven stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.